Role of 3-monthly long-acting injectable paliperidone in the maintenance of schizophrenia

AIMS: Paliperidone palmitate 3-month (PP3M) represents a new long-acting injectable antipsychotic therapeutic option. This review aims: 1) to summarize available data relating to efficacy, safety, tolerability and costs of PP3M; 2) to describe hospitalization rate, occupational status, treatment pre...

Descripción completa

Detalles Bibliográficos
Autores principales: Brasso, Claudio, Bellino, Silvio, Bozzatello, Paola, Montemagni, Cristiana, Rocca, Paola
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5683787/
https://www.ncbi.nlm.nih.gov/pubmed/29158676
http://dx.doi.org/10.2147/NDT.S150568

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5683787/
https://www.ncbi.nlm.nih.gov/pubmed/29158676
http://dx.doi.org/10.2147/NDT.S150568

Ejemplares similares